BACKGROUND: The mechanism of CD4 T-cell decline in HIV-1 infection is unclear, but the association with plasma viral RNA load suggests viral replication is involved. Indeed, viremic controller patients with low viral RNA loads typically maintain high CD4 T-cell counts. Within a local cohort of 86 viremic controllers, we identify a subgroup (18 "discord controllers") with low CD4 T-cell counts that present clinical uncertainty. The underlying mechanism accounting for CD4 T-cell decline in the face of low or undetectable plasma (RNA) viral load remains unresolved. The objective of this study was to investigate the viral and host immune system dynamics in discord controllers by measuring cellular HIV-1 DNA load, T-cell populations, and T-cell activation markers. METHODS: We compared discord controllers (viral RNA load <2000 copies/mL, <450 CD4 T-cells/mm) with typical controllers (viral RNA load <2000 copies/mL, >450 CD4 T-cells/mm) and progressors (viral RNA load >10,000 copies/mL, <450 CD4 T-cells/mm). We quantified CD4/CD8 naive/central memory/effector memory subsets (CD45RA/RO ± CD62L), activation levels (CD38HLA-DR), and HIV-1 DNA load. RESULTS: Discord controllers resembled progressors showing high viral DNA load, depletion of naive CD4 T-cells, and higher activation in all CD4 T-cell subsets, compared with typical controllers. They were similar to typical controllers with lower CD8 T-cell activation compared with progressors. CONCLUSIONS: Our data are consistent with a relationship between CD4 T-cell activation and disease progression. HIV-1 DNA load may be a better marker of viral replication and disease progression than viral RNA load. Lower level CD8 T-cell activation correlates with low viral RNA load but not with disease progression or viral DNA load.
BACKGROUND: The mechanism of CD4 T-cell decline in HIV-1 infection is unclear, but the association with plasma viral RNA load suggests viral replication is involved. Indeed, viremic controller patients with low viral RNA loads typically maintain high CD4 T-cell counts. Within a local cohort of 86 viremic controllers, we identify a subgroup (18 "discord controllers") with low CD4 T-cell counts that present clinical uncertainty. The underlying mechanism accounting for CD4 T-cell decline in the face of low or undetectable plasma (RNA) viral load remains unresolved. The objective of this study was to investigate the viral and host immune system dynamics in discord controllers by measuring cellular HIV-1 DNA load, T-cell populations, and T-cell activation markers. METHODS: We compared discord controllers (viral RNA load <2000 copies/mL, <450 CD4 T-cells/mm) with typical controllers (viral RNA load <2000 copies/mL, >450 CD4 T-cells/mm) and progressors (viral RNA load >10,000 copies/mL, <450 CD4 T-cells/mm). We quantified CD4/CD8 naive/central memory/effector memory subsets (CD45RA/RO ± CD62L), activation levels (CD38HLA-DR), and HIV-1 DNA load. RESULTS: Discord controllers resembled progressors showing high viral DNA load, depletion of naive CD4 T-cells, and higher activation in all CD4 T-cell subsets, compared with typical controllers. They were similar to typical controllers with lower CD8 T-cell activation compared with progressors. CONCLUSIONS: Our data are consistent with a relationship between CD4 T-cell activation and disease progression. HIV-1 DNA load may be a better marker of viral replication and disease progression than viral RNA load. Lower level CD8 T-cell activation correlates with low viral RNA load but not with disease progression or viral DNA load.
Authors: R P Bucy; R D Hockett; C A Derdeyn; M S Saag; K Squires; M Sillers; R T Mitsuyasu; J M Kilby Journal: J Clin Invest Date: 1999-05-15 Impact factor: 14.808
Authors: Hanna Dreja; Eithne O'Sullivan; Corinna Pade; Kelli M Greene; Hongmei Gao; Keith Aubin; James Hand; Are Isaksen; Carl D'Souza; Werner Leber; David Montefiori; Michael S Seaman; Jane Anderson; Chloe Orkin; Aine McKnight Journal: J Gen Virol Date: 2010-08-04 Impact factor: 3.891
Authors: Richard Tilling; Sabine Kinloch; Li-Ean Goh; David Cooper; Luc Perrin; Fiona Lampe; John Zaunders; Bruno Hoen; Chris Tsoukas; Jan Andersson; George Janossy Journal: AIDS Date: 2002-03-08 Impact factor: 4.177
Authors: Steven G Deeks; Christina M R Kitchen; Lea Liu; Hua Guo; Ron Gascon; Amy B Narváez; Peter Hunt; Jeffrey N Martin; James O Kahn; Jay Levy; Michael S McGrath; Frederick M Hecht Journal: Blood Date: 2004-04-29 Impact factor: 22.113
Authors: Adriana Andrade; Justin R Bailey; Jie Xu; Frances H Philp; Thomas C Quinn; Thomas M Williams; Stuart C Ray; David L Thomas; Joel N Blankson Journal: Clin Infect Dis Date: 2008-04-15 Impact factor: 9.079
Authors: Peter W Hunt; Jason Brenchley; Elizabeth Sinclair; Joseph M McCune; Michelle Roland; Kimberly Page-Shafer; Priscilla Hsue; Brinda Emu; Melissa Krone; Harry Lampiris; Daniel Douek; Jeffrey N Martin; Steven G Deeks Journal: J Infect Dis Date: 2008-01-01 Impact factor: 5.226
Authors: Mariya V Sivay; Jessica M Fogel; Jing Wang; Yinfeng Zhang; Estelle Piwowar-Manning; William Clarke; Autumn Breaud; Joel Blankson; Erica L Hamilton; Kathleen Kahn; Amanda Selin; F Xavier Gomez-Olive; Catherine MacPhail; James P Hughes; Audrey Pettifor; Susan H Eshleman Journal: HIV Clin Trials Date: 2018-12-06
Authors: Jonathan Z Li; Florencia P Segal; Ronald J Bosch; Christina M Lalama; Carla Roberts-Toler; Heloise Delagreverie; Rachel Getz; Pilar Garcia-Broncano; Jennifer Kinslow; Randall Tressler; Cornelius N Van Dam; Michael Keefer; Mary Carrington; Mathias Lichterfeld; Daniel Kuritzkes; Xu G Yu; Alan Landay; Paul E Sax Journal: Clin Infect Dis Date: 2020-04-10 Impact factor: 9.079
Authors: Jonathan Z Li; Kelly B Arnold; Janet Lo; Anne-Sophie Dugast; Jill Plants; Heather J Ribaudo; Kevin Cesa; Andrea Heisey; Daniel R Kuritzkes; Douglas A Lauffenburger; Galit Alter; Alan Landay; Steven Grinspoon; Florencia Pereyra Journal: Open Forum Infect Dis Date: 2015-01-13 Impact factor: 3.835
Authors: Nichole R Klatt; Steven E Bosinger; Melicent Peck; Laura E Richert-Spuhler; Anke Heigele; Jillian P Gile; Nirav Patel; Jessica Taaffe; Boris Julg; David Camerini; Carlo Torti; Jeffrey N Martin; Steven G Deeks; Elizabeth Sinclair; Frederick M Hecht; Michael M Lederman; Mirko Paiardini; Frank Kirchhoff; Jason M Brenchley; Peter W Hunt; Guido Silvestri Journal: PLoS Pathog Date: 2014-08-28 Impact factor: 6.823
Authors: Jintanat Ananworanich; Carlo P Sacdalan; Suteeraporn Pinyakorn; Nicolas Chomont; Mark de Souza; Tassanee Luekasemsuk; Alexandra Schuetz; Shelly J Krebs; Robin Dewar; Linda Jagodzinski; Sasiwimol Ubolyam; Rapee Trichavaroj; Sodsai Tovanabutra; Serena Spudich; Victor Valcour; Irini Sereti; Nelson Michael; Merlin Robb; Praphan Phanuphak; Jerome H Kim; Nittaya Phanuphak Journal: J Virus Erad Date: 2016
Authors: Jintanat Ananworanich; Nicolas Chomont; Leigh Ann Eller; Eugene Kroon; Sodsai Tovanabutra; Meera Bose; Martin Nau; James L K Fletcher; Somporn Tipsuk; Claire Vandergeeten; Robert J O'Connell; Suteeraporn Pinyakorn; Nelson Michael; Nittaya Phanuphak; Merlin L Robb Journal: EBioMedicine Date: 2016-07-20 Impact factor: 8.143